{"transactions":[{"id":951490,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":70320,"kind":"person","name":"Lowenthal Richard E","position":1,"cik":"0001378550","reported_name":"Lowenthal Richard E","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Stock Option (right to buy)","published_at":"2026-01-05T21:19:13.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":240000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest in a series of 48 equal monthly installments measured from January 1, 2026."}],"balance_after":240000,"derivative":{"exercise_price":11.49,"expiration_date":"2036-01-01","underlying":"Common Stock","underlying_shares":240000},"source":{"system":"sec-edgar","filing":"0001378550-26-000003","document":"form4-01052026_090159.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000137855026000003/form4-01052026_090159.xml","form_type":"4"}},{"id":951489,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":70320,"kind":"person","name":"Lowenthal Richard E","position":1,"cik":"0001378550","reported_name":"Lowenthal Richard E","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Stock option (right to buy)","published_at":"2026-01-05T21:19:13.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":875000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest in a series of 48 equal monthly installments measured from January 1, 2026."}],"balance_after":875000,"derivative":{"exercise_price":11.49,"expiration_date":"2036-01-01","underlying":"Common Stock","underlying_shares":875000},"source":{"system":"sec-edgar","filing":"0001378550-26-000003","document":"form4-01052026_090159.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000137855026000003/form4-01052026_090159.xml","form_type":"4"}},{"id":1057827,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":70320,"kind":"person","name":"Lowenthal Richard E","position":1,"cik":"0001378550","reported_name":"Lowenthal Richard E","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2025-08-22T20:30:16.000Z","date":"2025-08-21","kind":"sale","planned":true,"acquired":false,"shares":50000,"price":14.4869,"value":724345.0,"ownership":{"direct":false,"nature":"By Richard E. Lowenthal Charitable Remainder UniTrust Dated January 7, 2020"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold pursuant to a Rule 10b5-1 trading plan entered into on May 15, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $14.4869 and the range of prices were between $14.31 and $14.61. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person is trustee of the trust."}],"balance_after":1196494,"source":{"system":"sec-edgar","filing":"0001415889-25-022761","document":"form4-08222025_040804.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000141588925022761/form4-08222025_040804.xml","form_type":"4"}},{"id":1314776,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":70320,"kind":"person","name":"Lowenthal Richard E","position":1,"cik":"0001378550","reported_name":"Lowenthal Richard E","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Stock Option (right to buy)","published_at":"2025-01-03T21:30:37.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":261900,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest in a series of 48 equal monthly installments measured from January 1, 2025."}],"balance_after":261900,"derivative":{"exercise_price":10.71,"expiration_date":"2035-01-01","underlying":"Common Stock","underlying_shares":261900},"source":{"system":"sec-edgar","filing":"0001415889-25-000464","document":"form4-01032025_040132.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000141588925000464/form4-01032025_040132.xml","form_type":"4"}},{"id":1314775,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":70320,"kind":"person","name":"Lowenthal Richard E","position":1,"cik":"0001378550","reported_name":"Lowenthal Richard E","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Stock option (right to buy)","published_at":"2025-01-03T21:30:37.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":767600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest in a series of 48 equal monthly installments measured from January 1, 2025."}],"balance_after":767600,"derivative":{"exercise_price":10.71,"expiration_date":"2035-01-01","underlying":"Common Stock","underlying_shares":767600},"source":{"system":"sec-edgar","filing":"0001415889-25-000464","document":"form4-01032025_040132.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000141588925000464/form4-01032025_040132.xml","form_type":"4"}},{"id":1325403,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":70320,"kind":"person","name":"Lowenthal Richard E","position":1,"cik":"0001378550","reported_name":"Lowenthal Richard E","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2024-12-19T21:20:04.000Z","date":"2024-12-17","kind":"sale","planned":true,"acquired":false,"shares":50000,"price":11.6705,"value":583525.0,"ownership":{"direct":false,"nature":"By Lowenthal-Tanimoto Family Trust U/A DTD 4/3/2006"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold pursuant to a Rule 10b5-1 trading plan entered into on March 31, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The weighted average sale price for the transaction reported was $11.6705, and the range of prices were between $11.56 and $11.95. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The shares are held in trust for the benefit of the Reporting Person and his spouse.  The Reporting Person and his spouse are trustees of the trust."}],"balance_after":1098499,"source":{"system":"sec-edgar","filing":"0001415889-24-029851","document":"form4-12192024_041201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000141588924029851/form4-12192024_041201.xml","form_type":"4"}},{"id":1325402,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":70320,"kind":"person","name":"Lowenthal Richard E","position":1,"cik":"0001378550","reported_name":"Lowenthal Richard E","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2024-12-19T21:20:04.000Z","date":"2024-12-17","kind":"sale","planned":true,"acquired":false,"shares":50000,"price":11.6715,"value":583575.0,"ownership":{"direct":false,"nature":"By Sarina Tanimoto Charitable Remainder UniTrust Dated January 7, 2020"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold pursuant to a Rule 10b5-1 trading plan entered into on March 31, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $11.6715 and the range of prices were between $11.56 and $11.95. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person's spouse is trustee of the trust.  The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":1297447,"source":{"system":"sec-edgar","filing":"0001415889-24-029851","document":"form4-12192024_041201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000141588924029851/form4-12192024_041201.xml","form_type":"4"}},{"id":1335601,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":70320,"kind":"person","name":"Lowenthal Richard E","position":1,"cik":"0001378550","reported_name":"Lowenthal Richard E","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2024-12-11T23:30:05.000Z","date":"2024-12-10","kind":"sale","planned":true,"acquired":false,"shares":50000,"price":13.1631,"value":658155.0,"ownership":{"direct":false,"nature":"By Lowenthal-Tanimoto Family Trust U/A DTD 4/3/2006"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold pursuant to a Rule 10b5-1 trading plan entered into on March 31, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The weighted average sale price for the transaction reported was $13.1631, and the range of prices were between $12.94 and $13.535. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The shares are held in trust for the benefit of the Reporting Person and his spouse.  The Reporting Person and his spouse are trustees of the trust."}],"balance_after":1148499,"source":{"system":"sec-edgar","filing":"0001415889-24-029011","document":"form4-12112024_061201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000141588924029011/form4-12112024_061201.xml","form_type":"4"}},{"id":1335600,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":70320,"kind":"person","name":"Lowenthal Richard E","position":1,"cik":"0001378550","reported_name":"Lowenthal Richard E","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2024-12-11T23:30:05.000Z","date":"2024-12-10","kind":"sale","planned":true,"acquired":false,"shares":50000,"price":13.1653,"value":658265.0,"ownership":{"direct":false,"nature":"By Richard E. Lowenthal Charitable Remainder UniTrust Dated January 7, 2020"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold pursuant to a Rule 10b5-1 trading plan entered into on March 31, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $13.1653, and the range of prices were between $12.94 and $13.535. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person is trustee of the trust."}],"balance_after":1246494,"source":{"system":"sec-edgar","filing":"0001415889-24-029011","document":"form4-12112024_061201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000141588924029011/form4-12112024_061201.xml","form_type":"4"}},{"id":1339031,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":70320,"kind":"person","name":"Lowenthal Richard E","position":1,"cik":"0001378550","reported_name":"Lowenthal Richard E","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Stock Option (right to buy)","published_at":"2024-12-09T22:25:58.000Z","date":"2024-12-06","kind":"exercise","planned":false,"acquired":false,"shares":11876,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"25% of the shares subject to the option vested on the one year anniversary of the vesting commencement date and the balance of the shares vest in a series of thirty-six (36) successive equal monthly installments measured from the first anniversary of the vesting commencement date."}],"balance_after":338124,"derivative":{"exercise_price":8.42,"expiration_date":"2033-01-02","underlying":"Common Stock","underlying_shares":11876},"source":{"system":"sec-edgar","filing":"0001415889-24-028678","document":"form4-12092024_101253.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000141588924028678/form4-12092024_101253.xml","form_type":"4"}},{"id":1339030,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":70320,"kind":"person","name":"Lowenthal Richard E","position":1,"cik":"0001378550","reported_name":"Lowenthal Richard E","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Stock Option (right to buy)","published_at":"2024-12-09T22:25:58.000Z","date":"2024-12-06","kind":"exercise","planned":false,"acquired":false,"shares":13789,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"25% of the shares subject to the option vested on the one year anniversary of the vesting commencement date and the balance of the shares vest in a series of thirty-six (36) successive equal monthly installments measured from the first anniversary of the vesting commencement date."}],"balance_after":20684,"derivative":{"exercise_price":1.44,"expiration_date":"2031-12-13","underlying":"Common Stock","underlying_shares":13789},"source":{"system":"sec-edgar","filing":"0001415889-24-028678","document":"form4-12092024_101253.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000141588924028678/form4-12092024_101253.xml","form_type":"4"}},{"id":1339029,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":70320,"kind":"person","name":"Lowenthal Richard E","position":1,"cik":"0001378550","reported_name":"Lowenthal Richard E","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Stock Option (right to buy)","published_at":"2024-12-09T22:25:58.000Z","date":"2024-12-06","kind":"exercise","planned":false,"acquired":false,"shares":11876,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"25% of the shares subject to the option vested on the one year anniversary of the vesting commencement date and the balance of the shares vest in a series of thirty-six (36) successive equal monthly installments measured from the first anniversary of the vesting commencement date."}],"balance_after":1088124,"derivative":{"exercise_price":8.42,"expiration_date":"2033-01-02","underlying":"Common Stock","underlying_shares":11876},"source":{"system":"sec-edgar","filing":"0001415889-24-028678","document":"form4-12092024_101253.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000141588924028678/form4-12092024_101253.xml","form_type":"4"}},{"id":1339028,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":70320,"kind":"person","name":"Lowenthal Richard E","position":1,"cik":"0001378550","reported_name":"Lowenthal Richard E","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2024-12-09T22:25:58.000Z","date":"2024-12-06","kind":"exercise","planned":false,"acquired":true,"shares":11876,"price":8.42,"value":99995.92,"ownership":{"direct":false,"nature":"By Spouse"},"balance_after":3433512,"source":{"system":"sec-edgar","filing":"0001415889-24-028678","document":"form4-12092024_101253.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000141588924028678/form4-12092024_101253.xml","form_type":"4"}},{"id":1339027,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":70320,"kind":"person","name":"Lowenthal Richard E","position":1,"cik":"0001378550","reported_name":"Lowenthal Richard E","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2024-12-09T22:25:58.000Z","date":"2024-12-06","kind":"exercise","planned":false,"acquired":true,"shares":13789,"price":1.44,"value":19856.16,"ownership":{"direct":false,"nature":"By Spouse"},"balance_after":3421636,"source":{"system":"sec-edgar","filing":"0001415889-24-028678","document":"form4-12092024_101253.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000141588924028678/form4-12092024_101253.xml","form_type":"4"}},{"id":1339026,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":70320,"kind":"person","name":"Lowenthal Richard E","position":1,"cik":"0001378550","reported_name":"Lowenthal Richard E","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2024-12-09T22:25:58.000Z","date":"2024-12-06","kind":"exercise","planned":false,"acquired":true,"shares":11876,"price":8.42,"value":99995.92,"ownership":{"direct":true},"balance_after":4327189,"source":{"system":"sec-edgar","filing":"0001415889-24-028678","document":"form4-12092024_101253.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000141588924028678/form4-12092024_101253.xml","form_type":"4"}},{"id":1355762,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":70320,"kind":"person","name":"Lowenthal Richard E","position":1,"cik":"0001378550","reported_name":"Lowenthal Richard E","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2024-11-21T21:30:07.000Z","date":"2024-11-19","kind":"sale","planned":true,"acquired":false,"shares":50000,"price":13.949,"value":697450.0,"ownership":{"direct":false,"nature":"By Lowenthal-Tanimoto Family Trust U/A DTD 4/3/2006"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold pursuant to a Rule 10b5-1 trading plan entered into on March 31, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The weighted average sale price for the transaction reported was $13.949, and the range of prices were between $13.50 and $14.28. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The shares are held in trust for the benefit of the Reporting Person and his spouse.  The Reporting Person and his spouse are trustees of the trust."}],"balance_after":1198499,"source":{"system":"sec-edgar","filing":"0001415889-24-027411","document":"form4-11212024_041104.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000141588924027411/form4-11212024_041104.xml","form_type":"4"}},{"id":1355761,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":70320,"kind":"person","name":"Lowenthal Richard E","position":1,"cik":"0001378550","reported_name":"Lowenthal Richard E","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2024-11-21T21:30:07.000Z","date":"2024-11-19","kind":"sale","planned":true,"acquired":false,"shares":50000,"price":13.9502,"value":697510.0,"ownership":{"direct":false,"nature":"By Sarina Tanimoto Charitable Remainder UniTrust Dated January 7, 2020"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold pursuant to a Rule 10b5-1 trading plan entered into on March 31, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $13.9502 and the range of prices were between $13.50 and $14.25. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person's spouse is trustee of the trust.  The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":1347447,"source":{"system":"sec-edgar","filing":"0001415889-24-027411","document":"form4-11212024_041104.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000141588924027411/form4-11212024_041104.xml","form_type":"4"}},{"id":1365132,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":70320,"kind":"person","name":"Lowenthal Richard E","position":1,"cik":"0001378550","reported_name":"Lowenthal Richard E","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2024-11-14T21:30:08.000Z","date":"2024-11-12","kind":"sale","planned":true,"acquired":false,"shares":4876,"price":17.6416,"value":86020.4416,"ownership":{"direct":false,"nature":"By Lowenthal-Tanimoto Family Trust U/A DTD 4/3/2006"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold pursuant to a Rule 10b5-1 trading plan entered into on March 31, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The weighted average sale price for the transaction reported was $17.6416, and the range of prices were between $17.42 and $17.83. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"The shares are held in trust for the benefit of the Reporting Person and his spouse.  The Reporting Person and his spouse are trustees of the trust."}],"balance_after":1248499,"source":{"system":"sec-edgar","filing":"0001415889-24-026866","document":"form4-11142024_041104.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000141588924026866/form4-11142024_041104.xml","form_type":"4"}},{"id":1365131,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":70320,"kind":"person","name":"Lowenthal Richard E","position":1,"cik":"0001378550","reported_name":"Lowenthal Richard E","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2024-11-14T21:30:08.000Z","date":"2024-11-12","kind":"sale","planned":true,"acquired":false,"shares":45124,"price":16.7604,"value":756296.2896,"ownership":{"direct":false,"nature":"By Lowenthal-Tanimoto Family Trust U/A DTD 4/3/2006"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold pursuant to a Rule 10b5-1 trading plan entered into on March 31, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The weighted average sale price for the transaction reported was $16.7604, and the range of prices were between $16.40 and $17.39. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"The shares are held in trust for the benefit of the Reporting Person and his spouse.  The Reporting Person and his spouse are trustees of the trust."}],"balance_after":1253375,"source":{"system":"sec-edgar","filing":"0001415889-24-026866","document":"form4-11142024_041104.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000141588924026866/form4-11142024_041104.xml","form_type":"4"}},{"id":1365130,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":70320,"kind":"person","name":"Lowenthal Richard E","position":1,"cik":"0001378550","reported_name":"Lowenthal Richard E","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2024-11-14T21:30:08.000Z","date":"2024-11-12","kind":"sale","planned":true,"acquired":false,"shares":4955,"price":17.643,"value":87421.065,"ownership":{"direct":false,"nature":"By Richard E. Lowenthal Charitable Remainder UniTrust Dated January 7, 2020"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold pursuant to a Rule 10b5-1 trading plan entered into on March 31, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The weighted average sale price for the transaction reported was $17.643, and the range of prices were between $17.42 and $17.85. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person is trustee of the trust."}],"balance_after":1296494,"source":{"system":"sec-edgar","filing":"0001415889-24-026866","document":"form4-11142024_041104.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000141588924026866/form4-11142024_041104.xml","form_type":"4"}},{"id":1365129,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":70320,"kind":"person","name":"Lowenthal Richard E","position":1,"cik":"0001378550","reported_name":"Lowenthal Richard E","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2024-11-14T21:30:08.000Z","date":"2024-11-12","kind":"sale","planned":true,"acquired":false,"shares":45045,"price":16.7589,"value":754904.6505,"ownership":{"direct":false,"nature":"By Richard E. Lowenthal Charitable Remainder UniTrust Dated January 7, 2020"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold pursuant to a Rule 10b5-1 trading plan entered into on March 31, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $16.7589, and the range of prices were between $16.405 and $17.395. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person is trustee of the trust."}],"balance_after":1301449,"source":{"system":"sec-edgar","filing":"0001415889-24-026866","document":"form4-11142024_041104.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000141588924026866/form4-11142024_041104.xml","form_type":"4"}},{"id":1384803,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":70320,"kind":"person","name":"Lowenthal Richard E","position":1,"cik":"0001378550","reported_name":"Lowenthal Richard E","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2024-10-17T20:30:28.000Z","date":"2024-10-15","kind":"sale","planned":true,"acquired":false,"shares":50000,"price":14.8764,"value":743820.0,"ownership":{"direct":false,"nature":"By Lowenthal-Tanimoto Family Trust U/A DTD 4/3/2006"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold pursuant to a Rule 10b5-1 trading plan entered into on March 31, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The weighted average sale price for the transaction reported was $14.8764, and the range of prices were between $14.26 and $15.26. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"The shares are held in trust for the benefit of the Reporting Person and his spouse.  The Reporting Person and his spouse are trustees of the trust."}],"balance_after":1298499,"source":{"system":"sec-edgar","filing":"0001415889-24-025368","document":"form4-10172024_041024.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000141588924025368/form4-10172024_041024.xml","form_type":"4"}},{"id":1384802,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":70320,"kind":"person","name":"Lowenthal Richard E","position":1,"cik":"0001378550","reported_name":"Lowenthal Richard E","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2024-10-17T20:30:28.000Z","date":"2024-10-15","kind":"sale","planned":true,"acquired":false,"shares":1450,"price":15.2539,"value":22118.155,"ownership":{"direct":false,"nature":"By Sarina Tanimoto Charitable Remainder UniTrust Dated January 7, 2020"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold pursuant to a Rule 10b5-1 trading plan entered into on March 31, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The weighted average sale price for the transaction reported was $15.2539 and the range of prices were between $15.25 and $15.26. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person's spouse is trustee of the Trust. The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":1397447,"source":{"system":"sec-edgar","filing":"0001415889-24-025368","document":"form4-10172024_041024.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000141588924025368/form4-10172024_041024.xml","form_type":"4"}},{"id":1384801,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":70320,"kind":"person","name":"Lowenthal Richard E","position":1,"cik":"0001378550","reported_name":"Lowenthal Richard E","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2024-10-17T20:30:28.000Z","date":"2024-10-15","kind":"sale","planned":true,"acquired":false,"shares":48550,"price":14.8642,"value":721656.91,"ownership":{"direct":false,"nature":"By Sarina Tanimoto Charitable Remainder UniTrust Dated January 7, 2020"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold pursuant to a Rule 10b5-1 trading plan entered into on March 31, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $14.8642 and the range of prices were between $14.245 and $15.245. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person's spouse is trustee of the Trust. The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":1398897,"source":{"system":"sec-edgar","filing":"0001415889-24-025368","document":"form4-10172024_041024.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000141588924025368/form4-10172024_041024.xml","form_type":"4"}},{"id":1388114,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":70320,"kind":"person","name":"Lowenthal Richard E","position":1,"cik":"0001378550","reported_name":"Lowenthal Richard E","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2024-10-10T20:27:30.000Z","date":"2024-10-08","kind":"sale","planned":true,"acquired":false,"shares":50000,"price":13.8278,"value":691390.0,"ownership":{"direct":false,"nature":"By Lowenthal-Tanimoto Family Trust U/A DTD 4/3/2006"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold pursuant to a Rule 10b5-1 trading plan entered into on March 31, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The weighted average sale price for the transaction reported was $13.8278, and the range of prices were between $13.60 and $14.035. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The shares are held in trust for the benefit of the Reporting Person and his spouse.  The Reporting Person and his spouse are trustees of the trust."}],"balance_after":1348499,"source":{"system":"sec-edgar","filing":"0001415889-24-024980","document":"form4-10102024_081026.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000141588924024980/form4-10102024_081026.xml","form_type":"4"}},{"id":1388113,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":70320,"kind":"person","name":"Lowenthal Richard E","position":1,"cik":"0001378550","reported_name":"Lowenthal Richard E","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2024-10-10T20:27:30.000Z","date":"2024-10-08","kind":"sale","planned":true,"acquired":false,"shares":50000,"price":13.8277,"value":691385.0,"ownership":{"direct":false,"nature":"By Richard Lowenthal Charitable Remainder UniTrust Dated January 7, 2020"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold pursuant to a Rule 10b5-1 trading plan entered into on March 31, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $13.8277, and the range of prices were between $13.60 and $14.025. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person is trustee of the trust."}],"balance_after":1346494,"source":{"system":"sec-edgar","filing":"0001415889-24-024980","document":"form4-10102024_081026.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000141588924024980/form4-10102024_081026.xml","form_type":"4"}},{"id":1402407,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":70320,"kind":"person","name":"Lowenthal Richard E","position":1,"cik":"0001378550","reported_name":"Lowenthal Richard E","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2024-09-19T20:26:21.000Z","date":"2024-09-17","kind":"sale","planned":true,"acquired":false,"shares":50000,"price":12.9336,"value":646680.0,"ownership":{"direct":false,"nature":"By Lowenthal-Tanimoto Family Trust U/A DTD 4/3/2006"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold pursuant to a Rule 10b5-1 trading plan entered into on March 31, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The weighted average sale price for the transaction reported was $12.9336, and the range of prices were between $12.65 and $13.31. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The shares are held in trust for the benefit of the Reporting Person and his spouse.  The Reporting Person and his spouse are trustees of the trust."}],"balance_after":1398499,"source":{"system":"sec-edgar","filing":"0001415889-24-023709","document":"form4-09192024_080917.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000141588924023709/form4-09192024_080917.xml","form_type":"4"}},{"id":1402406,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":70320,"kind":"person","name":"Lowenthal Richard E","position":1,"cik":"0001378550","reported_name":"Lowenthal Richard E","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2024-09-19T20:26:21.000Z","date":"2024-09-17","kind":"sale","planned":true,"acquired":false,"shares":50000,"price":12.9305,"value":646525.0,"ownership":{"direct":false,"nature":"By Sarina Tanimoto Charitable Remainder UniTrust Dated January 7, 2020"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold pursuant to a Rule 10b5-1 trading plan entered into on March 31, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $12.9305 and the range of prices were between $12.645 and $13.24. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person's spouse is trustee of the trust.  The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":1447447,"source":{"system":"sec-edgar","filing":"0001415889-24-023709","document":"form4-09192024_080917.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000141588924023709/form4-09192024_080917.xml","form_type":"4"}},{"id":1408663,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":70320,"kind":"person","name":"Lowenthal Richard E","position":1,"cik":"0001378550","reported_name":"Lowenthal Richard E","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2024-09-12T20:24:19.000Z","date":"2024-09-10","kind":"sale","planned":true,"acquired":false,"shares":50000,"price":11.4982,"value":574910.0,"ownership":{"direct":false,"nature":"By Lowenthal-Tanimoto Family Trust U/A DTD 4/3/2006"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold pursuant to a Rule 10b5-1 trading plan entered into on March 31, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The weighted average sale price for the transaction reported was $11.4982, and the range of prices were between $11.28 and $11.82. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The shares are held in trust for the benefit of the Reporting Person and his spouse.  The Reporting Person and his spouse are trustees of the trust."}],"balance_after":1448499,"source":{"system":"sec-edgar","filing":"0001415889-24-023290","document":"form4-09122024_080915.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000141588924023290/form4-09122024_080915.xml","form_type":"4"}},{"id":1408662,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":70320,"kind":"person","name":"Lowenthal Richard E","position":1,"cik":"0001378550","reported_name":"Lowenthal Richard E","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2024-09-12T20:24:19.000Z","date":"2024-09-10","kind":"sale","planned":true,"acquired":false,"shares":50000,"price":11.4973,"value":574865.0,"ownership":{"direct":false,"nature":"By Richard Lowenthal Charitable Remainder UniTrust Dated January 7, 2020"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold pursuant to a Rule 10b5-1 trading plan entered into on March 31, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $11.4973, and the range of prices were between $11.28 and $11.82. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person is trustee of the trust."}],"balance_after":1396494,"source":{"system":"sec-edgar","filing":"0001415889-24-023290","document":"form4-09122024_080915.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000141588924023290/form4-09122024_080915.xml","form_type":"4"}},{"id":1426531,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":70320,"kind":"person","name":"Lowenthal Richard E","position":1,"cik":"0001378550","reported_name":"Lowenthal Richard E","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2024-08-21T22:47:25.000Z","date":"2024-08-20","kind":"sale","planned":true,"acquired":false,"shares":2261,"price":16.2532,"value":36748.4852,"ownership":{"direct":false,"nature":"By Lowenthal-Tanimoto Family Trust U/A DTD 4/3/2006"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold pursuant to a Rule 10b5-1 trading plan entered into on March 31, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The weighted average sale price for the transaction report was $16.2532 and the range of prices were between $16.12 and $16.34. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares old at each separate price will be provided."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"The shares are held in trust for the benefit of the Reporting Person and his spouse.  The Reporting Person and his spouse are trustees of the trust."}],"balance_after":1498499,"source":{"system":"sec-edgar","filing":"0001415889-24-021877","document":"form4-08212024_100821.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000141588924021877/form4-08212024_100821.xml","form_type":"4"}},{"id":1426530,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":70320,"kind":"person","name":"Lowenthal Richard E","position":1,"cik":"0001378550","reported_name":"Lowenthal Richard E","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2024-08-21T22:47:25.000Z","date":"2024-08-20","kind":"sale","planned":true,"acquired":false,"shares":11523,"price":15.6234,"value":180028.4382,"ownership":{"direct":false,"nature":"By Lowenthal-Tanimoto Family Trust U/A DTD 4/3/2006"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold pursuant to a Rule 10b5-1 trading plan entered into on March 31, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The weighted average sale price for the transaction report was $15.6234,and the range of prices were between $15.10 and $16.09. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares old at each separate price will be provided."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"The shares are held in trust for the benefit of the Reporting Person and his spouse.  The Reporting Person and his spouse are trustees of the trust."}],"balance_after":1500760,"source":{"system":"sec-edgar","filing":"0001415889-24-021877","document":"form4-08212024_100821.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000141588924021877/form4-08212024_100821.xml","form_type":"4"}},{"id":1426529,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":70320,"kind":"person","name":"Lowenthal Richard E","position":1,"cik":"0001378550","reported_name":"Lowenthal Richard E","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2024-08-21T22:47:25.000Z","date":"2024-08-20","kind":"sale","planned":true,"acquired":false,"shares":36216,"price":14.7576,"value":534461.2416,"ownership":{"direct":false,"nature":"By Lowenthal-Tanimoto Family Trust U/A DTD 4/3/2006"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold pursuant to a Rule 10b5-1 trading plan entered into on March 31, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The weighted average sale price for the transaction report was $14.7576,and the range of prices were between $14.09 and $15.09. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares old at each separate price will be provided."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"The shares are held in trust for the benefit of the Reporting Person and his spouse.  The Reporting Person and his spouse are trustees of the trust."}],"balance_after":1512283,"source":{"system":"sec-edgar","filing":"0001415889-24-021877","document":"form4-08212024_100821.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000141588924021877/form4-08212024_100821.xml","form_type":"4"}},{"id":1426528,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":70320,"kind":"person","name":"Lowenthal Richard E","position":1,"cik":"0001378550","reported_name":"Lowenthal Richard E","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2024-08-21T22:47:25.000Z","date":"2024-08-20","kind":"sale","planned":true,"acquired":false,"shares":2300,"price":16.2589,"value":37395.47,"ownership":{"direct":false,"nature":"By Sarina Tanimoto Charitable Remainder UniTrust Dated January 7, 2020"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold pursuant to a Rule 10b5-1 trading plan entered into on March 31, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The weighted average sale price for the transaction report was $16.2589 and the range of prices were between $16.15 and $16.36. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares old at each separate price will be provided."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person's spouse is trustee of the trust.  The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":1497447,"source":{"system":"sec-edgar","filing":"0001415889-24-021877","document":"form4-08212024_100821.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000141588924021877/form4-08212024_100821.xml","form_type":"4"}},{"id":1426527,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":70320,"kind":"person","name":"Lowenthal Richard E","position":1,"cik":"0001378550","reported_name":"Lowenthal Richard E","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2024-08-21T22:47:25.000Z","date":"2024-08-20","kind":"sale","planned":true,"acquired":false,"shares":11756,"price":15.6129,"value":183545.2524,"ownership":{"direct":false,"nature":"By Sarina Tanimoto Charitable Remainder UniTrust Dated January 7, 2020"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold pursuant to a Rule 10b5-1 trading plan entered into on March 31, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The weighted average sale price for the transaction report was $15.6129 and the range of prices were between $15.10 and $16.09. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares old at each separate price will be provided."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person's spouse is trustee of the trust.  The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":1499747,"source":{"system":"sec-edgar","filing":"0001415889-24-021877","document":"form4-08212024_100821.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000141588924021877/form4-08212024_100821.xml","form_type":"4"}},{"id":1426526,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":70320,"kind":"person","name":"Lowenthal Richard E","position":1,"cik":"0001378550","reported_name":"Lowenthal Richard E","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2024-08-21T22:47:25.000Z","date":"2024-08-20","kind":"sale","planned":true,"acquired":false,"shares":35944,"price":14.7565,"value":530407.636,"ownership":{"direct":false,"nature":"By Sarina Tanimoto Charitable Remainder UniTrust Dated January 7, 2020"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold pursuant to a Rule 10b5-1 trading plan entered into on March 31, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction report was $14.7565 and the range of prices were between $14.09 and $15.09. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares old at each separate price will be provided."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person's spouse is trustee of the trust.  The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":1511503,"source":{"system":"sec-edgar","filing":"0001415889-24-021877","document":"form4-08212024_100821.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000141588924021877/form4-08212024_100821.xml","form_type":"4"}},{"id":1432530,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":70320,"kind":"person","name":"Lowenthal Richard E","position":1,"cik":"0001378550","reported_name":"Lowenthal Richard E","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2024-08-15T20:30:08.000Z","date":"2024-08-13","kind":"sale","planned":true,"acquired":false,"shares":35363,"price":12.7659,"value":451440.5217,"ownership":{"direct":false,"nature":"By Lowenthal-Tanimoto Family Trust U/A DTD 4/3/2006"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold pursuant to a Rule 10b5-1 trading plan entered into on March 31, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The weighted average sale price for the transaction reported was $12.7659, and the range of prices were between $12.35 and $13.095. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"The shares are held in trust for the benefit of the Reporting Person and his spouse.  The Reporting Person and his spouse are trustees of the trust."}],"balance_after":1548499,"source":{"system":"sec-edgar","filing":"0001415889-24-021362","document":"form4-08152024_040805.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000141588924021362/form4-08152024_040805.xml","form_type":"4"}},{"id":1432529,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":70320,"kind":"person","name":"Lowenthal Richard E","position":1,"cik":"0001378550","reported_name":"Lowenthal Richard E","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2024-08-15T20:30:08.000Z","date":"2024-08-13","kind":"sale","planned":true,"acquired":false,"shares":14637,"price":11.7734,"value":172327.2558,"ownership":{"direct":false,"nature":"By Lowenthal-Tanimoto Family Trust U/A DTD 4/3/2006"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold pursuant to a Rule 10b5-1 trading plan entered into on March 31, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The weighted average sale price for the transaction reported was $11.7734, and the range of prices were between $11.335 and $12.215. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"The shares are held in trust for the benefit of the Reporting Person and his spouse.  The Reporting Person and his spouse are trustees of the trust."}],"balance_after":1583862,"source":{"system":"sec-edgar","filing":"0001415889-24-021362","document":"form4-08152024_040805.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000141588924021362/form4-08152024_040805.xml","form_type":"4"}},{"id":1432528,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":70320,"kind":"person","name":"Lowenthal Richard E","position":1,"cik":"0001378550","reported_name":"Lowenthal Richard E","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2024-08-15T20:30:08.000Z","date":"2024-08-13","kind":"sale","planned":true,"acquired":false,"shares":35401,"price":12.7646,"value":451879.6046,"ownership":{"direct":false,"nature":"By Richard E. Lowenthal Charitable Remainder UniTrust Dated January 7, 2020"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold pursuant to a Rule 10b5-1 trading plan entered into on March 31, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The weighted average sale price for the transaction reported was $12.7646, and the range of prices were between $12.24 and $13.085. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person is trustee of the trust."}],"balance_after":1446494,"source":{"system":"sec-edgar","filing":"0001415889-24-021362","document":"form4-08152024_040805.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000141588924021362/form4-08152024_040805.xml","form_type":"4"}},{"id":1432527,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":70320,"kind":"person","name":"Lowenthal Richard E","position":1,"cik":"0001378550","reported_name":"Lowenthal Richard E","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2024-08-15T20:30:08.000Z","date":"2024-08-13","kind":"sale","planned":true,"acquired":false,"shares":14599,"price":11.7753,"value":171907.6047,"ownership":{"direct":false,"nature":"By Richard E. Lowenthal Charitable Remainder UniTrust Dated January 7, 2020"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold pursuant to a Rule 10b5-1 trading plan entered into on March 31, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $11.7753, and the range of prices were between $11.31 and $12.22. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person is trustee of the trust."}],"balance_after":1481895,"source":{"system":"sec-edgar","filing":"0001415889-24-021362","document":"form4-08152024_040805.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000141588924021362/form4-08152024_040805.xml","form_type":"4"}},{"id":1451800,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":70320,"kind":"person","name":"Lowenthal Richard E","position":1,"cik":"0001378550","reported_name":"Lowenthal Richard E","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2024-07-18T20:30:11.000Z","date":"2024-07-16","kind":"sale","planned":true,"acquired":false,"shares":50000,"price":11.4031,"value":570155.0,"ownership":{"direct":false,"nature":"By Lowenthal-Tanimoto Family Trust U/A DTD 4/3/2006"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold pursuant to a Rule 10b5-1 trading plan entered into on March 31, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The weighted average sale price for the transaction reported was $11.4031, and the range of prices were between $11.11 and $11.82. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The shares are held in trust for the benefit of the Reporting Person and his spouse.  The Reporting Person and his spouse are trustees of the trust."}],"balance_after":1598499,"source":{"system":"sec-edgar","filing":"0001415889-24-019770","document":"form4-07182024_040707.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000141588924019770/form4-07182024_040707.xml","form_type":"4"}},{"id":1451799,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":70320,"kind":"person","name":"Lowenthal Richard E","position":1,"cik":"0001378550","reported_name":"Lowenthal Richard E","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2024-07-18T20:30:11.000Z","date":"2024-07-16","kind":"sale","planned":true,"acquired":false,"shares":50000,"price":11.4028,"value":570140.0,"ownership":{"direct":false,"nature":"By Sarina Tanimoto Charitable Remainder UniTrust Dated January 7, 2020"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold pursuant to a Rule 10b5-1 trading plan entered into on March 31, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $11.4028, and the range of prices were between $11.11 and $11.825. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person's spouse is trustee of the trust.  The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":1547447,"source":{"system":"sec-edgar","filing":"0001415889-24-019770","document":"form4-07182024_040707.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000141588924019770/form4-07182024_040707.xml","form_type":"4"}},{"id":1456208,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":70320,"kind":"person","name":"Lowenthal Richard E","position":1,"cik":"0001378550","reported_name":"Lowenthal Richard E","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2024-07-11T21:03:23.000Z","date":"2024-07-09","kind":"sale","planned":true,"acquired":false,"shares":50000,"price":9.6168,"value":480840.0,"ownership":{"direct":false,"nature":"By Lowenthal-Tanimoto Family Trust U/A DTD 4/3/2006"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold pursuant to a Rule 10b5-1 trading plan entered into on March 31, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The weighted average sale price for the transaction reported was $9.6168, and the range of prices were between $9.38 and $9.805. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The shares are held in trust for the benefit of the Reporting Person and his spouse.  The Reporting Person and his spouse are trustees of the trust."}],"balance_after":1648499,"source":{"system":"sec-edgar","filing":"0001415889-24-019493","document":"form4-07112024_090720.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000141588924019493/form4-07112024_090720.xml","form_type":"4"}},{"id":1456207,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":70320,"kind":"person","name":"Lowenthal Richard E","position":1,"cik":"0001378550","reported_name":"Lowenthal Richard E","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2024-07-11T21:03:23.000Z","date":"2024-07-09","kind":"sale","planned":true,"acquired":false,"shares":50000,"price":9.6177,"value":480885.0,"ownership":{"direct":false,"nature":"By Richard Lowenthal Charitable Remainder UniTrust Dated January 7, 2020"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold pursuant to a Rule 10b5-1 trading plan entered into on March 31, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $9.6177, and the range of prices were between $9.38 and $9.81. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person is trustee of the trust."}],"balance_after":1496494,"source":{"system":"sec-edgar","filing":"0001415889-24-019493","document":"form4-07112024_090720.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000141588924019493/form4-07112024_090720.xml","form_type":"4"}},{"id":1480712,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":70320,"kind":"person","name":"Lowenthal Richard E","position":1,"cik":"0001378550","reported_name":"Lowenthal Richard E","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2024-06-13T20:30:21.000Z","date":"2024-06-12","kind":"sale","planned":true,"acquired":false,"shares":48028,"price":9.1447,"value":439201.6516,"ownership":{"direct":false,"nature":"By Lowenthal-Tanimoto Family Trust U/A DTD 4/3/2006"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold pursuant to a Rule 10b5-1 trading plan entered into on March 31, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The weighted average sale price for the transaction reported was $9.1447, and the range of prices were between $9.01 and $9.315. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The shares are held in trust for the benefit of the Reporting Person and his spouse.  The Reporting Person and his spouse are trustees of the trust."}],"balance_after":1698499,"source":{"system":"sec-edgar","filing":"0001415889-24-016678","document":"form4-06132024_040607.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000141588924016678/form4-06132024_040607.xml","form_type":"4"}},{"id":1480711,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":70320,"kind":"person","name":"Lowenthal Richard E","position":1,"cik":"0001378550","reported_name":"Lowenthal Richard E","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2024-06-13T20:30:21.000Z","date":"2024-06-12","kind":"sale","planned":true,"acquired":false,"shares":47834,"price":9.1454,"value":437461.0636,"ownership":{"direct":false,"nature":"By Richard E. Lowenthal Charitable Remainder UniTrust Dated January 7, 2020"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold pursuant to a Rule 10b5-1 trading plan entered into on March 31, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The weighted average sale price for the transaction reported was $9.1454, and the range of prices were between $9.01 and $9.315. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person is trustee of the trust."}],"balance_after":1546494,"source":{"system":"sec-edgar","filing":"0001415889-24-016678","document":"form4-06132024_040607.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000141588924016678/form4-06132024_040607.xml","form_type":"4"}},{"id":1480710,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":70320,"kind":"person","name":"Lowenthal Richard E","position":1,"cik":"0001378550","reported_name":"Lowenthal Richard E","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2024-06-13T20:30:21.000Z","date":"2024-06-11","kind":"sale","planned":true,"acquired":false,"shares":1972,"price":9.0039,"value":17755.6908,"ownership":{"direct":false,"nature":"By Lowenthal-Tanimoto Family Trust U/A DTD 4/3/2006"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold pursuant to a Rule 10b5-1 trading plan entered into on March 31, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The weighted average sale price for the transaction reported was $9.0039, and the range of prices were between $9.00 and $9.02. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each\nseparate price will be provided."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The shares are held in trust for the benefit of the Reporting Person and his spouse.  The Reporting Person and his spouse are trustees of the trust."}],"balance_after":1746527,"source":{"system":"sec-edgar","filing":"0001415889-24-016678","document":"form4-06132024_040607.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000141588924016678/form4-06132024_040607.xml","form_type":"4"}},{"id":1480709,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":70320,"kind":"person","name":"Lowenthal Richard E","position":1,"cik":"0001378550","reported_name":"Lowenthal Richard E","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2024-06-13T20:30:21.000Z","date":"2024-06-11","kind":"sale","planned":true,"acquired":false,"shares":2166,"price":9.002,"value":19498.332,"ownership":{"direct":false,"nature":"By Richard E. Lowenthal Charitable Remainder UniTrust Dated January 7, 2020"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold pursuant to a Rule 10b5-1 trading plan entered into on March 31, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $9.002, and the range of prices were between $9.00 and $9.02. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each\nseparate price will be provided."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person is trustee of the trust."}],"balance_after":1594328,"source":{"system":"sec-edgar","filing":"0001415889-24-016678","document":"form4-06132024_040607.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000141588924016678/form4-06132024_040607.xml","form_type":"4"}},{"id":1514289,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":70320,"kind":"person","name":"Lowenthal Richard E","position":1,"cik":"0001378550","reported_name":"Lowenthal Richard E","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2024-05-16T23:51:59.000Z","date":"2024-05-16","kind":"sale","planned":true,"acquired":false,"shares":44350,"price":9.0577,"value":401708.995,"ownership":{"direct":false,"nature":"By Lowenthal-Tanimoto Family Trust U/A DTD 4/3/2006"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold pursuant to a Rule 10b5-1 trading plan entered into on March 31, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The weighted average sale price for the transaction reported was $9.0577, and the range of prices were between $9.00 and $9.14. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The shares are held in trust for the benefit of the Reporting Person and his spouse.  The Reporting Person and his spouse are trustees of the trust."}],"balance_after":1748499,"source":{"system":"sec-edgar","filing":"0001415889-24-013387","document":"form4-05162024_110552.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000141588924013387/form4-05162024_110552.xml","form_type":"4"}},{"id":1514288,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":70320,"kind":"person","name":"Lowenthal Richard E","position":1,"cik":"0001378550","reported_name":"Lowenthal Richard E","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2024-05-16T23:51:59.000Z","date":"2024-05-16","kind":"sale","planned":true,"acquired":false,"shares":44746,"price":9.0581,"value":405313.7426,"ownership":{"direct":false,"nature":"By Sarina Tanimoto Charitable Remainder UniTrust Dated January 7, 2020"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold pursuant to a Rule 10b5-1 trading plan entered into on March 31, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The weighted average sale price for the transaction reported was $9.0581, and the range of prices were between $9.00 and $9.13. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person's spouse is trustee of the trust.  The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":1597447,"source":{"system":"sec-edgar","filing":"0001415889-24-013387","document":"form4-05162024_110552.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000141588924013387/form4-05162024_110552.xml","form_type":"4"}},{"id":1514287,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":70320,"kind":"person","name":"Lowenthal Richard E","position":1,"cik":"0001378550","reported_name":"Lowenthal Richard E","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2024-05-16T23:51:59.000Z","date":"2024-05-15","kind":"sale","planned":true,"acquired":false,"shares":2766,"price":9.0403,"value":25005.4698,"ownership":{"direct":false,"nature":"By Lowenthal-Tanimoto Family Trust U/A DTD 4/3/2006"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold pursuant to a Rule 10b5-1 trading plan entered into on March 31, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The weighted average sale price for the transaction reported was $9.0403, and the range of prices were between $9.00 and $9.12. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The shares are held in trust for the benefit of the Reporting Person and his spouse.  The Reporting Person and his spouse are trustees of the trust."}],"balance_after":1792849,"source":{"system":"sec-edgar","filing":"0001415889-24-013387","document":"form4-05162024_110552.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000141588924013387/form4-05162024_110552.xml","form_type":"4"}},{"id":1514286,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":70320,"kind":"person","name":"Lowenthal Richard E","position":1,"cik":"0001378550","reported_name":"Lowenthal Richard E","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2024-05-16T23:51:59.000Z","date":"2024-05-15","kind":"sale","planned":true,"acquired":false,"shares":2381,"price":9.0547,"value":21559.2407,"ownership":{"direct":false,"nature":"By Sarina Tanimoto Charitable Remainder UniTrust Dated January 7. 2020"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold pursuant to a Rule 10b5-1 trading plan entered into on March 31, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The weighted average sale price for the transaction reported was $9.0547, and the range of prices were between $9.00 and $9.16. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person's spouse is trustee of the trust.  The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":1642193,"source":{"system":"sec-edgar","filing":"0001415889-24-013387","document":"form4-05162024_110552.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000141588924013387/form4-05162024_110552.xml","form_type":"4"}},{"id":1514285,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":70320,"kind":"person","name":"Lowenthal Richard E","position":1,"cik":"0001378550","reported_name":"Lowenthal Richard E","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2024-05-16T23:51:59.000Z","date":"2024-05-14","kind":"sale","planned":true,"acquired":false,"shares":2884,"price":9.0058,"value":25972.7272,"ownership":{"direct":false,"nature":"By Lowenthal-Tanimoto Family Trust U/A DTD 4/3/2006"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold pursuant to a Rule 10b5-1 trading plan entered into on March 31, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The weighted average sale price for the transaction reported was $9.0058, and the range of prices were between $9.00 and $9.06. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The shares are held in trust for the benefit of the Reporting Person and his spouse.  The Reporting Person and his spouse are trustees of the trust."}],"balance_after":1795615,"source":{"system":"sec-edgar","filing":"0001415889-24-013387","document":"form4-05162024_110552.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000141588924013387/form4-05162024_110552.xml","form_type":"4"}},{"id":1514284,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":70320,"kind":"person","name":"Lowenthal Richard E","position":1,"cik":"0001378550","reported_name":"Lowenthal Richard E","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2024-05-16T23:51:59.000Z","date":"2024-05-14","kind":"sale","planned":true,"acquired":false,"shares":2873,"price":9.0084,"value":25881.1332,"ownership":{"direct":false,"nature":"By Sarina Tanimoto Charitable Remainder UniTrust Dated January 7, 2020"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold pursuant to a Rule 10b5-1 trading plan entered into on March 31, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $9.0084, and the range of prices were between $9.00 and $9.06. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person's spouse is trustee of the trust.  The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":1644574,"source":{"system":"sec-edgar","filing":"0001415889-24-013387","document":"form4-05162024_110552.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000141588924013387/form4-05162024_110552.xml","form_type":"4"}},{"id":1522149,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":70320,"kind":"person","name":"Lowenthal Richard E","position":1,"cik":"0001378550","reported_name":"Lowenthal Richard E","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2024-05-09T22:57:04.000Z","date":"2024-05-07","kind":"sale","planned":true,"acquired":false,"shares":50000,"price":9.3446,"value":467230.0,"ownership":{"direct":false,"nature":"By Lowenthal-Tanimoto Family Trust U/A DTD 4/3/2006"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold pursuant to a Rule 10b5-1 trading plan entered into on March 31, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The weighted average sale price for the transaction reported was $9.3446, and the range of prices were between $9.14 and $9.50. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The shares are held in trust for the benefit of the Reporting Person and his spouse.  The Reporting Person and his spouse are trustees of the trust."}],"balance_after":1798499,"source":{"system":"sec-edgar","filing":"0001415889-24-012768","document":"form4-05092024_100554.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000141588924012768/form4-05092024_100554.xml","form_type":"4"}},{"id":1522148,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":70320,"kind":"person","name":"Lowenthal Richard E","position":1,"cik":"0001378550","reported_name":"Lowenthal Richard E","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2024-05-09T22:57:04.000Z","date":"2024-05-07","kind":"sale","planned":true,"acquired":false,"shares":50000,"price":9.3427,"value":467135.0,"ownership":{"direct":false,"nature":"By Richard Lowenthal Charitable Remainder UniTrust Dated January 7, 2020"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold pursuant to a Rule 10b5-1 trading plan entered into on March 31, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $9.3427, and the range of prices were between $9.14 and $9.50. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person is trustee of the trust."}],"balance_after":1596494,"source":{"system":"sec-edgar","filing":"0001415889-24-012768","document":"form4-05092024_100554.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000141588924012768/form4-05092024_100554.xml","form_type":"4"}},{"id":1536202,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":70320,"kind":"person","name":"Lowenthal Richard E","position":1,"cik":"0001378550","reported_name":"Lowenthal Richard E","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Stock Option (right to buy)","published_at":"2024-04-24T22:17:43.000Z","date":"2024-04-23","kind":"exercise","planned":false,"acquired":false,"shares":48260,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"25% of the shares subject to the option vested on the one year anniversary of the vesting commencement date and the balance of the shares vest in a series of thirty-six (36) successive equal monthly installments measured from the first anniversary of the vesting commencement date."}],"balance_after":34473,"derivative":{"exercise_price":1.44,"expiration_date":"2031-12-13","underlying":"Common Stock","underlying_shares":48260},"source":{"system":"sec-edgar","filing":"0001415889-24-011469","document":"form4-04242024_100435.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000141588924011469/form4-04242024_100435.xml","form_type":"4"}},{"id":1536201,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":70320,"kind":"person","name":"Lowenthal Richard E","position":1,"cik":"0001378550","reported_name":"Lowenthal Richard E","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Stock Option (right to buy)","published_at":"2024-04-24T22:17:43.000Z","date":"2024-04-23","kind":"exercise","planned":false,"acquired":false,"shares":82733,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"25% of the shares subject to the option vested on the one year anniversary of the vesting commencement date and the balance of the shares vest in a series of thirty-six (36) successive equal monthly installments measured from the first anniversary of the vesting commencement date."}],"balance_after":0,"derivative":{"exercise_price":0.84,"expiration_date":"2029-12-16","underlying":"Common Stock","underlying_shares":82733},"source":{"system":"sec-edgar","filing":"0001415889-24-011469","document":"form4-04242024_100435.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000141588924011469/form4-04242024_100435.xml","form_type":"4"}},{"id":1536200,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":70320,"kind":"person","name":"Lowenthal Richard E","position":1,"cik":"0001378550","reported_name":"Lowenthal Richard E","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2024-04-24T22:17:43.000Z","date":"2024-04-23","kind":"exercise","planned":false,"acquired":true,"shares":48260,"price":1.44,"value":69494.4,"ownership":{"direct":false,"nature":"By Spouse"},"balance_after":3407847,"source":{"system":"sec-edgar","filing":"0001415889-24-011469","document":"form4-04242024_100435.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000141588924011469/form4-04242024_100435.xml","form_type":"4"}},{"id":1536199,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":70320,"kind":"person","name":"Lowenthal Richard E","position":1,"cik":"0001378550","reported_name":"Lowenthal Richard E","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2024-04-24T22:17:43.000Z","date":"2024-04-23","kind":"exercise","planned":false,"acquired":true,"shares":82733,"price":0.84,"value":69495.72,"ownership":{"direct":false,"nature":"By Spouse"},"balance_after":3359587,"source":{"system":"sec-edgar","filing":"0001415889-24-011469","document":"form4-04242024_100435.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000141588924011469/form4-04242024_100435.xml","form_type":"4"}},{"id":1537589,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":70320,"kind":"person","name":"Lowenthal Richard E","position":1,"cik":"0001378550","reported_name":"Lowenthal Richard E","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Stock Option (right to buy)","published_at":"2024-04-22T23:22:25.000Z","date":"2024-04-19","kind":"exercise","planned":false,"acquired":false,"shares":69444,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"25% of the shares subject to the option vested on the one year anniversary of the vesting commencement date and the balance of the shares vest in a series of thirty-six (36) successive equal monthly installments measured from the first anniversary of the vesting commencement date."}],"balance_after":166936,"derivative":{"exercise_price":1.44,"expiration_date":"2031-12-13","underlying":"Common Stock","underlying_shares":69444},"source":{"system":"sec-edgar","filing":"0001415889-24-011334","document":"form4-04222024_110419.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000141588924011334/form4-04222024_110419.xml","form_type":"4"}},{"id":1537588,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":70320,"kind":"person","name":"Lowenthal Richard E","position":1,"cik":"0001378550","reported_name":"Lowenthal Richard E","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Stock Option (right to buy)","published_at":"2024-04-22T23:22:25.000Z","date":"2024-04-19","kind":"exercise","planned":false,"acquired":false,"shares":119047,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"25% of the shares subject to the option vested on the one year anniversary of the vesting commencement date and the balance of the shares vest in a series of thirty-six (36) successive equal monthly installments measured from the first anniversary of the vesting commencement date."}],"balance_after":117333,"derivative":{"exercise_price":0.84,"expiration_date":"2029-12-16","underlying":"Common Stock","underlying_shares":119047},"source":{"system":"sec-edgar","filing":"0001415889-24-011334","document":"form4-04222024_110419.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000141588924011334/form4-04222024_110419.xml","form_type":"4"}},{"id":1537587,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":70320,"kind":"person","name":"Lowenthal Richard E","position":1,"cik":"0001378550","reported_name":"Lowenthal Richard E","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2024-04-22T23:22:25.000Z","date":"2024-04-19","kind":"exercise","planned":false,"acquired":true,"shares":69444,"price":1.44,"value":99999.36,"ownership":{"direct":true},"balance_after":4315313,"source":{"system":"sec-edgar","filing":"0001415889-24-011334","document":"form4-04222024_110419.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000141588924011334/form4-04222024_110419.xml","form_type":"4"}},{"id":1537586,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":70320,"kind":"person","name":"Lowenthal Richard E","position":1,"cik":"0001378550","reported_name":"Lowenthal Richard E","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2024-04-22T23:22:25.000Z","date":"2024-04-19","kind":"exercise","planned":false,"acquired":true,"shares":119047,"price":0.84,"value":99999.48,"ownership":{"direct":true},"balance_after":4245869,"source":{"system":"sec-edgar","filing":"0001415889-24-011334","document":"form4-04222024_110419.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000141588924011334/form4-04222024_110419.xml","form_type":"4"}},{"id":1539993,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":70320,"kind":"person","name":"Lowenthal Richard E","position":1,"cik":"0001378550","reported_name":"Lowenthal Richard E","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2024-04-17T22:40:40.000Z","date":"2024-04-16","kind":"sale","planned":true,"acquired":false,"shares":50000,"price":9.2797,"value":463985.0,"ownership":{"direct":false,"nature":"By Lowenthal-Tanimoto Family Trust U/A DTD 4/3/2006"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold pursuant to a Rule 10b5-1 trading plan entered into on March 31, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The weighted average sale price for the transaction reported was $9.2797, and the range of prices were between $9.05 and $9.47. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The shares are held in trust for the benefit of the Reporting Person and his spouse.  The Reporting Person and his spouse are trustees of the trust."}],"balance_after":1848499,"source":{"system":"sec-edgar","filing":"0001415889-24-011055","document":"form4-04172024_100434.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000141588924011055/form4-04172024_100434.xml","form_type":"4"}},{"id":1539992,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":70320,"kind":"person","name":"Lowenthal Richard E","position":1,"cik":"0001378550","reported_name":"Lowenthal Richard E","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2024-04-17T22:40:40.000Z","date":"2024-04-16","kind":"sale","planned":true,"acquired":false,"shares":50000,"price":9.2804,"value":464020.0,"ownership":{"direct":false,"nature":"By Sarina Tanimoto Charitable Remainder UniTrust Dated January 7, 2020"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold pursuant to a Rule 10b5-1 trading plan entered into on March 31, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $9.2804, and the range of prices were between $9.05 and $9.46. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person's spouse is trustee of the trust.  The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":1647447,"source":{"system":"sec-edgar","filing":"0001415889-24-011055","document":"form4-04172024_100434.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000141588924011055/form4-04172024_100434.xml","form_type":"4"}},{"id":1543799,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":70320,"kind":"person","name":"Lowenthal Richard E","position":1,"cik":"0001378550","reported_name":"Lowenthal Richard E","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2024-04-10T21:36:54.000Z","date":"2024-04-09","kind":"sale","planned":true,"acquired":false,"shares":50000,"price":9.277,"value":463850.0,"ownership":{"direct":false,"nature":"By Lowenthal-Tanimoto Family Trust U/A DTD 4/3/2006"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold pursuant to a Rule 10b5-1 trading plan entered into on March 31, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The weighted average sale price for the transaction reported was $9.277, and the range of prices were between $9.13 and $9.91. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The shares are held in trust for the benefit of the Reporting Person and his spouse.  The Reporting Person and his spouse are trustees of the trust."}],"balance_after":1898499,"source":{"system":"sec-edgar","filing":"0001415889-24-010659","document":"form4-04102024_090447.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000141588924010659/form4-04102024_090447.xml","form_type":"4"}},{"id":1543798,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":70320,"kind":"person","name":"Lowenthal Richard E","position":1,"cik":"0001378550","reported_name":"Lowenthal Richard E","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2024-04-10T21:36:54.000Z","date":"2024-04-09","kind":"sale","planned":true,"acquired":false,"shares":50000,"price":9.2777,"value":463885.0,"ownership":{"direct":false,"nature":"By Richard Lowenthal Charitable Remainder UniTrust Dated January 7, 2020"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold pursuant to a Rule 10b5-1 trading plan entered into on March 31, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $9.2777, and the range of prices were between $9.13 and $9.91. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person is trustee of the trust."}],"balance_after":1646494,"source":{"system":"sec-edgar","filing":"0001415889-24-010659","document":"form4-04102024_090447.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000141588924010659/form4-04102024_090447.xml","form_type":"4"}},{"id":1560581,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":70320,"kind":"person","name":"Lowenthal Richard E","position":1,"cik":"0001378550","reported_name":"Lowenthal Richard E","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2024-03-26T22:48:19.000Z","date":"2024-03-25","kind":"sale","planned":true,"acquired":false,"shares":47632,"price":9.1236,"value":434575.3152,"ownership":{"direct":false,"nature":"By Lowenthal-Tanimoto Family Trust U/A DTD 4/3/2006"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold pursuant to a Rule 10b5-1 trading plan entered into on March 31, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The weighted average sale price for the transaction reported was $9.1236, and the range of prices were between $9.03 and $9.36. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The shares are held in trust for the benefit of the Reporting Person and his spouse.  The Reporting Person and his spouse are trustees of the trust."}],"balance_after":1948499,"source":{"system":"sec-edgar","filing":"0001415889-24-009154","document":"form4-03262024_100309.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000141588924009154/form4-03262024_100309.xml","form_type":"4"}},{"id":1560580,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":70320,"kind":"person","name":"Lowenthal Richard E","position":1,"cik":"0001378550","reported_name":"Lowenthal Richard E","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2024-03-26T22:48:19.000Z","date":"2024-03-25","kind":"sale","planned":true,"acquired":false,"shares":47635,"price":9.1238,"value":434612.213,"ownership":{"direct":false,"nature":"By Sarina Tanimoto Charitable Remainder UniTrust Dated January 7, 2020"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold pursuant to a Rule 10b5-1 trading plan entered into on March 31, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The weighted average sale price for the transaction reported was $9.1238, and the range of prices were between $9.03 and $9.36. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person's spouse is trustee of the trust. The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":1697447,"source":{"system":"sec-edgar","filing":"0001415889-24-009154","document":"form4-03262024_100309.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000141588924009154/form4-03262024_100309.xml","form_type":"4"}},{"id":1560579,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":70320,"kind":"person","name":"Lowenthal Richard E","position":1,"cik":"0001378550","reported_name":"Lowenthal Richard E","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2024-03-26T22:48:19.000Z","date":"2024-03-22","kind":"sale","planned":true,"acquired":false,"shares":1326,"price":9.0132,"value":11951.5032,"ownership":{"direct":false,"nature":"By Lowenthal-Tanimoto Family Trust U/A DTD 4/3/2006"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold pursuant to a Rule 10b5-1 trading plan entered into on March 31, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The weighted average sale price for the transaction reported was $9.0132, and the range of prices were between $9.00 and $9.07. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The shares are held in trust for the benefit of the Reporting Person and his spouse.  The Reporting Person and his spouse are trustees of the trust."}],"balance_after":1996131,"source":{"system":"sec-edgar","filing":"0001415889-24-009154","document":"form4-03262024_100309.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000141588924009154/form4-03262024_100309.xml","form_type":"4"}},{"id":1560578,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":70320,"kind":"person","name":"Lowenthal Richard E","position":1,"cik":"0001378550","reported_name":"Lowenthal Richard E","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2024-03-26T22:48:19.000Z","date":"2024-03-22","kind":"sale","planned":true,"acquired":false,"shares":1017,"price":9.0298,"value":9183.3066,"ownership":{"direct":false,"nature":"By Sarina Tanimoto Charitable Remainder UniTrust Dated January 7, 2020"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold pursuant to a Rule 10b5-1 trading plan entered into on March 31, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $9.0298, and the range of prices were between $9.00 and $9.06. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person's spouse is trustee of the trust. The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":1745082,"source":{"system":"sec-edgar","filing":"0001415889-24-009154","document":"form4-03262024_100309.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000141588924009154/form4-03262024_100309.xml","form_type":"4"}},{"id":1564821,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":70320,"kind":"person","name":"Lowenthal Richard E","position":1,"cik":"0001378550","reported_name":"Lowenthal Richard E","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2024-03-22T01:51:24.000Z","date":"2024-03-21","kind":"sale","planned":true,"acquired":false,"shares":100,"price":9,"value":900.0,"ownership":{"direct":false,"nature":"By Lowenthal-Tanimoto Family Trust U/A DTD 4/3/2006"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold pursuant to a Rule 10b5-1 trading plan entered into on March 31, 2023."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The shares are held in trust for the benefit of the Reporting Person and his spouse.  The Reporting Person and his spouse are trustees of the trust."}],"balance_after":1997457,"source":{"system":"sec-edgar","filing":"0001415889-24-008901","document":"form4-03222024_010317.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000141588924008901/form4-03222024_010317.xml","form_type":"4"}},{"id":1564820,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":70320,"kind":"person","name":"Lowenthal Richard E","position":1,"cik":"0001378550","reported_name":"Lowenthal Richard E","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2024-03-22T01:51:24.000Z","date":"2024-03-21","kind":"sale","planned":true,"acquired":false,"shares":372,"price":9,"value":3348.0,"ownership":{"direct":false,"nature":"By Sarina Tanimoto Charitable Remainder UniTrust Dated January 7, 2020"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold pursuant to a Rule 10b5-1 trading plan entered into on March 31, 2023."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person's spouse is trustee of the trust. The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":1746099,"source":{"system":"sec-edgar","filing":"0001415889-24-008901","document":"form4-03222024_010317.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000141588924008901/form4-03222024_010317.xml","form_type":"4"}},{"id":1564819,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":70320,"kind":"person","name":"Lowenthal Richard E","position":1,"cik":"0001378550","reported_name":"Lowenthal Richard E","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2024-03-22T01:51:24.000Z","date":"2024-03-19","kind":"sale","planned":true,"acquired":false,"shares":942,"price":9.0376,"value":8513.4192,"ownership":{"direct":false,"nature":"By Lowenthal-Tanimoto Family Trust U/A DTD 4/3/2006"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold pursuant to a Rule 10b5-1 trading plan entered into on March 31, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The weighted average sale price for the transaction reported was $9.0376, and the range of prices were between $9.02 and $9.08. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The shares are held in trust for the benefit of the Reporting Person and his spouse.  The Reporting Person and his spouse are trustees of the trust."}],"balance_after":1997557,"source":{"system":"sec-edgar","filing":"0001415889-24-008901","document":"form4-03222024_010317.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000141588924008901/form4-03222024_010317.xml","form_type":"4"}},{"id":1564818,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":70320,"kind":"person","name":"Lowenthal Richard E","position":1,"cik":"0001378550","reported_name":"Lowenthal Richard E","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2024-03-22T01:51:24.000Z","date":"2024-03-19","kind":"sale","planned":true,"acquired":false,"shares":976,"price":9.0273,"value":8810.6448,"ownership":{"direct":false,"nature":"By Sarina Tanimoto Charitable Remainder UniTrust Dated January 7, 2020"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold pursuant to a Rule 10b5-1 trading plan entered into on March 31, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $9.0273, and the range of prices were between $9.01 and $9.09. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person's spouse is trustee of the trust. The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":1746471,"source":{"system":"sec-edgar","filing":"0001415889-24-008901","document":"form4-03222024_010317.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000141588924008901/form4-03222024_010317.xml","form_type":"4"}},{"id":1574775,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":70320,"kind":"person","name":"Lowenthal Richard E","position":1,"cik":"0001378550","reported_name":"Lowenthal Richard E","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2024-03-15T23:55:07.000Z","date":"2024-03-15","kind":"sale","planned":true,"acquired":false,"shares":48461,"price":9.1413,"value":442996.5393,"ownership":{"direct":false,"nature":"By Lowenthal-Tanimoto Family Trust U/A DTD 4/3/2006"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold pursuant to a Rule 10b5-1 trading plan entered into on March 31, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The weighted average sale price for the transaction reported was $9.1413, and the range of prices were between $9.02 and $9.22. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held in trust for the benefit of the Reporting Person and his spouse.  The Reporting Person and his spouse are trustees of the trust."}],"balance_after":1998499,"source":{"system":"sec-edgar","filing":"0001415889-24-008172","document":"form4-03152024_110359.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000141588924008172/form4-03152024_110359.xml","form_type":"4"}},{"id":1574774,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":70320,"kind":"person","name":"Lowenthal Richard E","position":1,"cik":"0001378550","reported_name":"Lowenthal Richard E","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2024-03-15T23:55:07.000Z","date":"2024-03-15","kind":"sale","planned":true,"acquired":false,"shares":48295,"price":9.1415,"value":441488.7425,"ownership":{"direct":false,"nature":"By Richard E. Lowenthal Charitable Remainder UniTrust Dated January 7, 2020"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold pursuant to a Rule 10b5-1 trading plan entered into on March 31, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The weighted average sale price for the transaction reported was $9.1415, and the range of prices were between $9.01 and $9.22. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is trustee of the trust."}],"balance_after":1696494,"source":{"system":"sec-edgar","filing":"0001415889-24-008172","document":"form4-03152024_110359.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000141588924008172/form4-03152024_110359.xml","form_type":"4"}},{"id":1574773,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":70320,"kind":"person","name":"Lowenthal Richard E","position":1,"cik":"0001378550","reported_name":"Lowenthal Richard E","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2024-03-15T23:55:07.000Z","date":"2024-03-14","kind":"sale","planned":true,"acquired":false,"shares":239,"price":9,"value":2151.0,"ownership":{"direct":false,"nature":"By Lowenthal-Tanimoto Family Trust U/A DTD 4/3/2006"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold pursuant to a Rule 10b5-1 trading plan entered into on March 31, 2023."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held in trust for the benefit of the Reporting Person and his spouse.  The Reporting Person and his spouse are trustees of the trust."}],"balance_after":2046960,"source":{"system":"sec-edgar","filing":"0001415889-24-008172","document":"form4-03152024_110359.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000141588924008172/form4-03152024_110359.xml","form_type":"4"}},{"id":1574772,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":70320,"kind":"person","name":"Lowenthal Richard E","position":1,"cik":"0001378550","reported_name":"Lowenthal Richard E","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2024-03-15T23:55:07.000Z","date":"2024-03-14","kind":"sale","planned":true,"acquired":false,"shares":205,"price":9,"value":1845.0,"ownership":{"direct":false,"nature":"By Richard E. Lowenthal Charitable Remainder UniTrust Dated January 7, 2020"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold pursuant to a Rule 10b5-1 trading plan entered into on March 31, 2023."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is trustee of the trust."}],"balance_after":1744789,"source":{"system":"sec-edgar","filing":"0001415889-24-008172","document":"form4-03152024_110359.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000141588924008172/form4-03152024_110359.xml","form_type":"4"}},{"id":1574771,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":70320,"kind":"person","name":"Lowenthal Richard E","position":1,"cik":"0001378550","reported_name":"Lowenthal Richard E","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2024-03-15T23:55:07.000Z","date":"2024-03-13","kind":"sale","planned":true,"acquired":false,"shares":1300,"price":9,"value":11700.0,"ownership":{"direct":false,"nature":"By Lowenthal-Tanimoto Family Trust U/A DTD 4/3/2006"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold pursuant to a Rule 10b5-1 trading plan entered into on March 31, 2023."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held in trust for the benefit of the Reporting Person and his spouse.  The Reporting Person and his spouse are trustees of the trust."}],"balance_after":2047199,"source":{"system":"sec-edgar","filing":"0001415889-24-008172","document":"form4-03152024_110359.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000141588924008172/form4-03152024_110359.xml","form_type":"4"}},{"id":1574770,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":70320,"kind":"person","name":"Lowenthal Richard E","position":1,"cik":"0001378550","reported_name":"Lowenthal Richard E","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2024-03-15T23:55:07.000Z","date":"2024-03-13","kind":"sale","planned":true,"acquired":false,"shares":1500,"price":9,"value":13500.0,"ownership":{"direct":false,"nature":"By Richard E. Lowenthal Charitable Remainder UniTrust Dated January 7, 2020"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold pursuant to a Rule 10b5-1 trading plan entered into on March 31, 2023."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is trustee of the trust."}],"balance_after":1744994,"source":{"system":"sec-edgar","filing":"0001415889-24-008172","document":"form4-03152024_110359.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000141588924008172/form4-03152024_110359.xml","form_type":"4"}},{"id":1607090,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":70320,"kind":"person","name":"Lowenthal Richard E","position":1,"cik":"0001378550","reported_name":"Lowenthal Richard E","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2024-03-02T01:17:51.000Z","date":"2024-02-29","kind":"sale","planned":true,"acquired":false,"shares":1000,"price":9.019,"value":9019.0,"ownership":{"direct":false,"nature":"By Sarina Tanimoto Charitable Remainder UniTrust Dated January 7, 2020"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold pursuant to a Rule 10b5-1 trading plan entered into on March 31, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The weighted average sale price for the transaction reported was $9.0190, and the range of prices were between $9.00 and $9.10.  Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"The Reporting Person's spouse is trustee of the trust.  The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose"}],"balance_after":1747447,"source":{"system":"sec-edgar","filing":"0001415889-24-006187","document":"form4-03022024_010345.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000141588924006187/form4-03022024_010345.xml","form_type":"4"}},{"id":1607089,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":70320,"kind":"person","name":"Lowenthal Richard E","position":1,"cik":"0001378550","reported_name":"Lowenthal Richard E","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2024-03-02T01:17:51.000Z","date":"2024-02-29","kind":"sale","planned":true,"acquired":false,"shares":1982,"price":9.0144,"value":17866.5408,"ownership":{"direct":false,"nature":"By Lowenthal-Tanimoto Family Trust U/A DTD 4/3/2006"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold pursuant to a Rule 10b5-1 trading plan entered into on March 31, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The weighted average sale price for the transaction reported was $9.0144, and the range of prices were between $9.00 and $9.10.  Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The shares are held in trust for the benefit of the Reporting Person and his spouse.  The Reporting Person and his spouse are trustees of the trust."}],"balance_after":2048499,"source":{"system":"sec-edgar","filing":"0001415889-24-006187","document":"form4-03022024_010345.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000141588924006187/form4-03022024_010345.xml","form_type":"4"}},{"id":1607088,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":70320,"kind":"person","name":"Lowenthal Richard E","position":1,"cik":"0001378550","reported_name":"Lowenthal Richard E","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2024-03-02T01:17:51.000Z","date":"2024-02-29","kind":"sale","planned":true,"acquired":false,"shares":800,"price":9.0188,"value":7215.04,"ownership":{"direct":false,"nature":"By Richard E. Lowenthal Charitable Remainder UniTrust Dated January 7, 2020"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold pursuant to a Rule 10b5-1 trading plan entered into on March 31, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $9.0188, and the range of prices were between $9.00 and $9.10.  Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person is trustee of the trust."}],"balance_after":1746494,"source":{"system":"sec-edgar","filing":"0001415889-24-006187","document":"form4-03022024_010345.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000141588924006187/form4-03022024_010345.xml","form_type":"4"}},{"id":1612331,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":70320,"kind":"person","name":"Lowenthal Richard E","position":1,"cik":"0001378550","reported_name":"Lowenthal Richard E","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2024-02-29T02:04:42.000Z","date":"2024-02-28","kind":"sale","planned":true,"acquired":false,"shares":24303,"price":9.0205,"value":219225.2115,"ownership":{"direct":false,"nature":"By Sarina Tanimoto Charitable Remainder UniTrust Dated January 7, 2020"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold pursuant to a Rule 10b5-1 trading plan entered into on March 31, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The weighted average sale price for the transaction reported was $9.0205, and the range of prices were between $9.00 and $9.17.  Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The Reporting Person's spouse is trustee of the trust.  The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose"}],"balance_after":1748447,"source":{"system":"sec-edgar","filing":"0001415889-24-005790","document":"form4-02292024_020233.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000141588924005790/form4-02292024_020233.xml","form_type":"4"}},{"id":1612330,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":70320,"kind":"person","name":"Lowenthal Richard E","position":1,"cik":"0001378550","reported_name":"Lowenthal Richard E","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2024-02-29T02:04:42.000Z","date":"2024-02-28","kind":"sale","planned":true,"acquired":false,"shares":49019,"price":9.0212,"value":442210.2028,"ownership":{"direct":false,"nature":"By Lowenthal-Tanimoto Family Trust U/A DTD 4/3/2006"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold pursuant to a Rule 10b5-1 trading plan entered into on March 31, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The weighted average sale price for the transaction reported was $9.0212, and the range of prices were between $9.00 and $9.19.  Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held in trust for the benefit of the Reporting Person and his spouse.  The Reporting Person and his spouse are trustees of the trust."}],"balance_after":2050481,"source":{"system":"sec-edgar","filing":"0001415889-24-005790","document":"form4-02292024_020233.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000141588924005790/form4-02292024_020233.xml","form_type":"4"}},{"id":1612329,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":70320,"kind":"person","name":"Lowenthal Richard E","position":1,"cik":"0001378550","reported_name":"Lowenthal Richard E","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2024-02-29T02:04:42.000Z","date":"2024-02-28","kind":"sale","planned":true,"acquired":false,"shares":25456,"price":9.0205,"value":229625.848,"ownership":{"direct":false,"nature":"By Richard E. Lowenthal Charitable Remainder UniTrust Dated January 7, 2020"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold pursuant to a Rule 10b5-1 trading plan entered into on March 31, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The weighted average sale price for the transaction reported was $9.0205, and the range of prices were between $9.00 and $9.19.  Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is trustee of the trust."}],"balance_after":1747294,"source":{"system":"sec-edgar","filing":"0001415889-24-005790","document":"form4-02292024_020233.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000141588924005790/form4-02292024_020233.xml","form_type":"4"}},{"id":1612328,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":70320,"kind":"person","name":"Lowenthal Richard E","position":1,"cik":"0001378550","reported_name":"Lowenthal Richard E","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2024-02-29T02:04:42.000Z","date":"2024-02-26","kind":"sale","planned":true,"acquired":false,"shares":100,"price":9.01,"value":901.0,"ownership":{"direct":false,"nature":"By Sarina Tanimoto Charitable Remainder Unitrust Dated January 7, 2020"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold pursuant to a Rule 10b5-1 trading plan entered into on March 31, 2023."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The Reporting Person's spouse is trustee of the trust.  The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose"}],"balance_after":1772750,"source":{"system":"sec-edgar","filing":"0001415889-24-005790","document":"form4-02292024_020233.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000141588924005790/form4-02292024_020233.xml","form_type":"4"}},{"id":1612327,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":70320,"kind":"person","name":"Lowenthal Richard E","position":1,"cik":"0001378550","reported_name":"Lowenthal Richard E","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2024-02-29T02:04:42.000Z","date":"2024-02-26","kind":"sale","planned":true,"acquired":false,"shares":500,"price":9.01,"value":4505.0,"ownership":{"direct":false,"nature":"By Lowenthal-Tanimoto Family Trust U/A DTD 4/3/2006"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold pursuant to a Rule 10b5-1 trading plan entered into on March 31, 2023."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held in trust for the benefit of the Reporting Person and his spouse.  The Reporting Person and his spouse are trustees of the trust."}],"balance_after":2099500,"source":{"system":"sec-edgar","filing":"0001415889-24-005790","document":"form4-02292024_020233.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000141588924005790/form4-02292024_020233.xml","form_type":"4"}},{"id":1612326,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":70320,"kind":"person","name":"Lowenthal Richard E","position":1,"cik":"0001378550","reported_name":"Lowenthal Richard E","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2024-02-29T02:04:42.000Z","date":"2024-02-26","kind":"sale","planned":true,"acquired":false,"shares":100,"price":9.01,"value":901.0,"ownership":{"direct":false,"nature":"By Richard E. Lowenthal Charitable Remainder UniTrust Dated January 7, 2020"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold pursuant to a Rule 10b5-1 trading plan entered into on March 31, 2023."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is trustee of the trust."}],"balance_after":1772750,"source":{"system":"sec-edgar","filing":"0001415889-24-005790","document":"form4-02292024_020233.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000141588924005790/form4-02292024_020233.xml","form_type":"4"}},{"id":1687852,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":70320,"kind":"person","name":"Lowenthal Richard E","position":1,"cik":"0001378550","reported_name":"Lowenthal Richard E","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Stock option (right to buy)","published_at":"2024-01-04T21:53:49.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By spouse"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"25% of the shares subject to the option shall vest on January 1, 2025, and the remaining shares will vest monthly thereafter over three years."}],"balance_after":300000,"derivative":{"exercise_price":5.58,"expiration_date":"2034-01-01","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001209191-24-000825","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000120919124000825/doc4.xml","form_type":"4"}},{"id":1687851,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":70320,"kind":"person","name":"Lowenthal Richard E","position":1,"cik":"0001378550","reported_name":"Lowenthal Richard E","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Stock option (right to buy)","published_at":"2024-01-04T21:53:49.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":880000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"25% of the shares subject to the option shall vest on January 1, 2025, and the remaining shares will vest monthly thereafter over three years."}],"balance_after":880000,"derivative":{"exercise_price":5.58,"expiration_date":"2034-01-01","underlying":"Common Stock","underlying_shares":880000},"source":{"system":"sec-edgar","filing":"0001209191-24-000825","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000120919124000825/doc4.xml","form_type":"4"}},{"id":1687850,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":70320,"kind":"person","name":"Lowenthal Richard E","position":1,"cik":"0001378550","reported_name":"Lowenthal Richard E","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-01-04T21:53:49.000Z","date":"2023-05-17","kind":"gift","planned":false,"acquired":true,"shares":1050000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Lowenthal-Tanimoto Family Trust U/A DTD 4/3/2006"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These shares are held in a trust for the benefit of the Reporting Person and his spouse. The Reporting Person and his spouse are trustees of the trust."}],"balance_after":2100000,"source":{"system":"sec-edgar","filing":"0001209191-24-000825","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000120919124000825/doc4.xml","form_type":"4"}},{"id":1687849,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":70320,"kind":"person","name":"Lowenthal Richard E","position":1,"cik":"0001378550","reported_name":"Lowenthal Richard E","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-01-04T21:53:49.000Z","date":"2023-05-17","kind":"gift","planned":false,"acquired":false,"shares":1050000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By spouse"},"balance_after":3276854,"source":{"system":"sec-edgar","filing":"0001209191-24-000825","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000120919124000825/doc4.xml","form_type":"4"}},{"id":1687848,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":70320,"kind":"person","name":"Lowenthal Richard E","position":1,"cik":"0001378550","reported_name":"Lowenthal Richard E","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-01-04T21:53:49.000Z","date":"2023-05-17","kind":"gift","planned":false,"acquired":true,"shares":1050000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Lowenthal-Tanimoto Family Trust U/A DTD 4/3/2006"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These shares are held in a trust for the benefit of the Reporting Person and his spouse. The Reporting Person and his spouse are trustees of the trust."}],"balance_after":1050000,"source":{"system":"sec-edgar","filing":"0001209191-24-000825","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000120919124000825/doc4.xml","form_type":"4"}},{"id":1687847,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":70320,"kind":"person","name":"Lowenthal Richard E","position":1,"cik":"0001378550","reported_name":"Lowenthal Richard E","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-01-04T21:53:49.000Z","date":"2023-05-17","kind":"gift","planned":false,"acquired":false,"shares":1050000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":4126822,"source":{"system":"sec-edgar","filing":"0001209191-24-000825","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000120919124000825/doc4.xml","form_type":"4"}},{"id":2062715,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":70320,"kind":"person","name":"Lowenthal Richard E","position":1,"cik":"0001378550","reported_name":"Lowenthal Richard E","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Stock option (right to buy)","published_at":"2023-01-05T22:00:30.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":350000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By spouse"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option vest on January 1, 2024, and the remaining shares will vest monthly thereafter over three years."}],"balance_after":350000,"derivative":{"exercise_price":8.42,"expiration_date":"2033-01-02","underlying":"Common Stock","underlying_shares":350000},"source":{"system":"sec-edgar","filing":"0001209191-23-001924","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000120919123001924/doc4.xml","form_type":"4"}},{"id":2062714,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":70320,"kind":"person","name":"Lowenthal Richard E","position":1,"cik":"0001378550","reported_name":"Lowenthal Richard E","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Stock option (right to buy)","published_at":"2023-01-05T22:00:30.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":1100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option vest on January 1, 2024, and the remaining shares will vest monthly thereafter over three years."}],"balance_after":1100000,"derivative":{"exercise_price":8.42,"expiration_date":"2033-01-02","underlying":"Common Stock","underlying_shares":1100000},"source":{"system":"sec-edgar","filing":"0001209191-23-001924","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000120919123001924/doc4.xml","form_type":"4"}},{"id":2120042,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":70320,"kind":"person","name":"Lowenthal Richard E","position":1,"cik":"0001378550","reported_name":"Lowenthal Richard E","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-11-10T23:00:28.000Z","date":"2022-11-08","kind":"grant","acquired":true,"shares":82733,"ownership":{"direct":false,"nature":"By spouse"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"Upon the closing of the Merger, each outstanding option to purchase shares of ARS common stock was assumed by the Issuer and converted into an option to purchase the Issuer's common stock."},{"field":"price","element":"transactionPricePerShare","label":"F11","text":"Received in exchange for a stock option to acquire 70,000 shares of common stock of ARS with an exercise price of $1.70 per share pursuant to the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"25% of the shares subject to the option vest on the one year anniversary of the vesting commencement date and the balance of the shares vest in a series of thirty-six (36) successive equal monthly installments measured from the first anniversary of the vesting commencement date."}],"balance_after":82733,"derivative":{"exercise_price":1.44,"expiration_date":"2031-12-13","underlying":"Common Stock","underlying_shares":82733},"source":{"system":"sec-edgar","filing":"0001209191-22-056442","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000120919122056442/doc4.xml","form_type":"4"}}],"next_cursor":"2022-11-10T23:00:28.000000Z,2120042"}